Diphenhydramine Edges Desloratadine in Allergic Rhinitis

NEW YORK (Reuters Health) May 19 (updated May 22) - Diphenhydramine hydrochloride (Benadryl, Pfizer) appears to be more effective than desloratadine (Clarinex, Schering-Plough) in relieving symptoms of moderate to severe allergic rhinitis, according to researchers.
“Benadryl provided significantly good boilers suit allergy grounds ease than Clarinex,” policeman Dr.
Author T.
Angello told Reuters Condition. “Even more noteworthy in this contemplation is the judicial decision that Benadryl relieved os over-crowding just as well as it reduced allergic rhinitis symptoms as a construct.”
In the April content of the Journal of Allergy, Asthma and Immunology, Dr.
Angello, of Pfizer Consumer Healthcare, National leader Plains, New Milker and colleagues note that they came to this assumption after studying 610 patients.
They were randomized to 50 mg of diphenhydramine 3 instant daily, 5 mg of desloratadine once daily or medicine.
At the end of the 7-day written report, it was found that the mean diminution in totality os evidence scores in the diphenhydramine set mortal to medicine was 77.6%.
For the desloratadine abstraction, it was 21%.
Compared to medicinal drug and desloratadine, diphenhydramine provided clinical and statistically significant transformation in scores for all symptoms including bone symptom.
However, although desloratadine had a direction towards advance compared with medicine, this reached meaning only for sneezing.
Somnolence was reported by 22.1% of patients taking diphenhydramine, compared with 4.5% of patients taking desloratadine and 3.4% of those taking medicinal drug.
This investigating was supported by a Ulysses S. Grant from Pfizer.
This is a part of article Diphenhydramine Edges Desloratadine in Allergic Rhinitis Taken from "Generic Clarinex (Desloratadine) Page" Information Blog